G. Steven Burrill

An introduction to Burrill Private Equity

Flash required to view this video. Download the latest version here

  
In addition to the venture funds, Burrill & Company has a dedicated private equity team focused on investing in undervalued small/midcap public companies and selected buy-outs and spin-outs from pharma, biotech, and other life sciences entities. This group leverages Burrill & Company’s deep industry experience and broad network to actively manage holdings and create value through working with management. Investment decisions come from proprietary deal flow created by the diverse business units within Burrill & Company, and these deals are not typically available to generalist managers.
 

Investment Approach



Burrill Private Equity Group’s active management creates value in investments through a structured and rigorous strategy.

Learn more

Burrill Global Healthcare Fund



The Burrill Global Select Healthcare Fund, L.P. is a private equity fund focused exclusively on human healthcare, biotechnology, diagnostics, nutraceuticals (wellness), agricultural biotechnology, biomaterials, and bioprocesses.


Learn more

Experienced, Global Team

We leverage our dedicated team's deep industry experience and broad network.


Meet the team